| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 691819 | Null | 0.0238174255956147 | 0.20979766 |
| NSC 704435 | Null | 0.0238174255956147 | 0.058360708 |
| NSC 706192 | Null | 0.0238174255956147 | 0.12904023 |
| NSC 710334 | Null | 0.0238174255956147 | 0.13517063 |
| NSC 725191 | 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol | 0.0238174255956147 | 0.21950242 |
| NSC 749292 | 3-methoxy-1-nitrosopyrido[3,2:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine | 0.0238174255956147 | 0.46452874 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0238174255956147 | 0.13107876 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0247979034812107 | 0.33967982 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0247979034812107 | 0.087888966 |
| NSC 176328 | Ellipticine, 6-(3-aminopropyl)-, dihydrochloride | 0.0247979034812107 | 0.1715712 |